Why Amarin Stock Was Plunging This Week
As of Friday before the market open, Amarin's stock was down by nearly 18% week to date, according to data provided by S&P Global Market Intelligence. Last Friday after market close, Amarin disclosed in a regulatory filing that it is ceasing operations in Germany, effective Sept. 1. The move comes after discussions with healthcare officials in that country failed to produce a reimbursement price Amarin considered "viable," in its words, for Vazkepa.